NEWS & EVENTS

MORE NEWS

NICE issues guidance for self-monitoring for people with AF or replacement heart valves

24th Sept 2014 The National Institute of Health and Care Excellence (NICE) has recommended self-monitoring of INR levels for people with atrial fibrillation and people with replacement heart valves - if the person prefers this form of testing and if the person or their carer is both physically and cognitively able to self-monitor effectively.

NICE revises its guidance on Atrial Fibrillation

The National Institute for Health and Care Excellence (NICE) has revised its guidance on Atrial Fibrillation. It says that anticoagulation may be with Apixaban, Dabigatran Etixialte, Rivaroxaban or a Vitamin K Antagonist (warfarin). It also states that aspirin should no longer be used as a sole therapy for stroke prevention in AF.

ROUTE MAP AND EUROPEAN ATLAS ON THE PREVENTION OF AF-RELATED STROKE

Despite clear clinical guidelines, millions of patients with atrial fibrillation (AF) across Europe are not given the correct therapy – leaving them at serious risk of a debilitating and potentially fatal AF-related stroke. This is a worrying finding of a landmark report covering 27 European countries, which highlights the enormous and often hidden burden of AF and AF-related stroke in Europe.


Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity

Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity Lifeblood and Anticoagulation Europe are both very concerned that the NICE recommendations that there should be equal access to VKAs (warfarin) and NOACs in the NICE approved indications are not being implemented. The NHS constitution states that patients should not be denied access to NICE approved drugs.

Ready for Change? An Audit of Local Commissioning

ACE’s new report shows there is a worrying trend that healthcare commissioners are not aware of how many people in their locality have one of the early warning signs of being at an increased risk of a stroke, atrial fibrillation (AF). With less than half of clinical commissioning groups (CCGs) having assessed the prevalence of the condition in their area, and almost two thirds not having assessed the cost of their anticoagulation service.

Dental Care for Patients Taking Anticoagulant or Antiplatelet Drugs

CLICK ON WORDS ABOVE AND HELP US BY COMPLETING THE QUESTIONNAIRE Help develop national clinical guidance for the management of patients needing dental treatment and who are taking anticoagulant or antiplatelet drugs. What is the aim of this questionnaire? The aim of this questionnaire is to explore patients’: • Views of their experiences of dental treatment in primary care when taking anticoagulant drugs. • Concerns they may have that might be addressed by the new guidance.


Welcome to Anticoagulation Europe

Do you have atrial fibrillation or have you had atrial fibrillation in the past?

European Heart Rhythm Association Patient Survey on Education and Compliance of Patients who are taking anticoagulants for stroke prevention in atrial fibrillation.  'Anti-clotting' medicines (anticoagulants) have been used for many years to prevent and treat blood clots. They are prescription medicines that make your blood less likely to clot. 

For all these treatments, the education of the patients is of utmost importance to reach best effect and lowest complication rates. This questionnaire will allow us to see the weaknesses and strengths of the education provided to patients by the health care team which then can adapt provided practices with a clear and appropriate information.

This survey aims to get information about the level of information understood by patients treated with oral anticoagulants in Europe. 
The collection of this data is carried out anonymously. 

https://www.surveymonkey.com/s/europeanpatientsurvey

Patient Experience Videos

By the end of 2016, there will be more than 1,000 people diagnosed with cancer every day in the UK. One of the side effects of cancer and its treatment can be blood clots. Blood clots pose a very significant risk to cancer patients. Up to 20% of cancer patients will experience a blood clot.

Many patients are not made aware of there risk of developing a blood clot when they have cancer.

Teresa’s video shares her experience of having cancer and deep vein thrombosis.

 

Are you taking warfarin? Are you thinking about self-monitoring your INR? Roy’s video shares his experience of the benefits of self-monitoring

INReview magazine

Order Your First Copy Free

We rely on donations and subscriptions so please consider joining or making a donation to enable us to coninue our work.

You can donate by clicking on to the link to right of this page. For easy ways to help us raise funds, at no cost to you, click on Give as You Live at the bottom of the page.

AntiCoagulation Europe are raising free donations through easyfundraising.

If you’re shopping online then you could help, and it won’t cost you a penny!

Here’s how easy it is to do:

Just visit a retailer or Amazon via the easyfundraising website and any purchases you make will raise a free donation for us. It’s that simple! 

They work with the leading retailers including Amazon, John Lewis, Argos and Marks and Spencer to name but a few.

It takes just a couple of minutes to register for free and no payment details are needed. 

Please visit their page to find out more:   

http://www.easyfundraising.org.uk/causes/anticoagulation

 

 

Join - Register with ACE to keep up to date

Donate - please support us

Newsletter sign-up

Anticoagulation Europe community on HealthUnlocked

Join the ACE health forum community and ask your questions and talk about your experiences.

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP. Registered Charity: 1090250
Privacy | Terms & Conditions © Anticoagulation Europe 2011
Web design by Bright White Space